| Moderna Switzerland GmbH - Spikevax LP.8.1 | | 70205 | | 01 | | Spikevax LP.8.1 | | | | J07BN01 | | | | 06.08.2025 | | |
| | Composition | | Suspension: SARS-CoV-2 LP.8.1 mRNA 50 µg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas trihydricus, saccharum, aqua ad iniectabile, pro dosi, natrium 0.017 mg pro dosi. | | Packungsbestandteile | | | | BAG: Principe actif | Concentr. |
|---|
| Sars-Cov-2 lp.8.1 Mrna | 50 mcg |
| | Agents auxilliaires | Concentr. | informations additionels |
|---|
| 1,2-dimyristoyl-Rac-Glycero-3-Polyethylenglycoli | 2000 | | | 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | | | Acide Acétique | | | | Aether Methylicus | | | | Cholesterol | | | | Mrna | 50 µg | | | Natrii Acetas Trihydricus | | | | Sodium | 0.017 mg | | | Saccharumaqua | | | | Sars-Cov-2 lp. | 8.1 | Suspension | | Trometamoli Hydrochloridum | | | | Trometamol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 74.72 | 96.45 | | | Non | | 002 | 10 | 747.20 | 816.55 | B | LS | Non |
|
|
